文献速递胃肠外科围术期管理与 ERAS

胃胃肠间质瘤现代手术入路的肿瘤学结局与生存分析

Oncologic outcomes and survival of modern surgical approaches for gastric gastrointestinal stromal tumor (GIST).
PubMed 文献 · Surg Endosc · 2024-08-23

基于美国国家癌症数据库2010–2020年15,022例胃GIST根治性手术患者的回顾性分析,比较机器人、腹腔镜与开腹手术。微创手术(MIS)较开腹手术住院时间更短、30天和90天死亡率更低,R0切除率相似;MIS组5年总生存优于开腹组,机器人组与腹腔镜组肿瘤学结局和生存无显著差异。

要点

  • 微创手术较开腹手术住院时间更短,30天和90天死亡率更低。
  • 微创手术与开腹手术的R0切除率相似。
  • 机器人组与腹腔镜组的R0切除率和生存结局无显著差异。

核心结论

  • 在经选择的胃GIST患者中可考虑采用微创手术入路。
  • 在微创手术中,机器人技术可作为腹腔镜手术的肿瘤学安全替代方案。

研究设计与样本

  • 回顾性分析美国国家癌症数据库2010–2020年接受根治性手术的成人胃GIST患者,排除中转开腹病例。
  • 共纳入15,022例患者,其中机器人组10.4%、腹腔镜组44.3%、开腹组45.3%。
  • 采用熵平衡调整组间差异,Kaplan-Meier法比较未调整5年生存。

主要发现

  • 63.2%为I期,70.6%接受部分胃切除术。
  • 微创手术较开腹手术住院时间更短(β:-2.58;95%CI:-2.82至-2.33)。
  • 微创手术较开腹手术30天死亡率更低(OR 0.45;95%CI:0.30–0.68),90天死亡率更低(OR 0.54;95%CI:0.39–0.74)。
  • 微创手术与开腹手术R0切除率相似(OR 1.00;95%CI:0.88–1.14)。
  • 机器人组与腹腔镜组住院时间(β:+0.25;95%CI:-0.14–0.64)、30天死亡率(OR 0.99;95%CI:0.40–2.46)、90天死亡率(OR 0.89;95%CI:0.47–1.70)及R0切除率(OR 1.02;95%CI:0.82–1.27)均相当。

关键数值与推荐

  • 微创手术较开腹手术5年总生存改善(log rank p < 0.001)。
  • 机器人组与腹腔镜组总生存无显著差异(log rank p = 0.44)。

临床怎么用

  • 对经选择的胃GIST患者,优先考虑微创手术以缩短住院时间并降低围术期死亡率。
  • 在微创手术中,机器人技术可作为腹腔镜的肿瘤学安全替代方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies have demonstrated comparable outcomes between laparoscopic and open resection of gastrointestinal stromal tumor (GIST). We sought to compare outcomes among robotic, laparoscopic, and open resection of gastric GIST in the era of expanding minimally invasive surgery. METHODS: A retrospective analysis was performed of adult patients with gastric GIST undergoing definitive surgery using the National Cancer Database from 2010 to 2020, excluding cases converted to open. Patients were stratified into minimally invasive surgery (MIS), (combined robotic (R) and laparoscopic (L)), and open (O). Hospital length of stay (LOS), 30-day mortality, 90-day mortality, and margin status were assessed. Subgroup analysis was performed to evaluate outcomes between R and L cohorts. Entropy balancing was used to adjust for intergroup differences. Kaplan-Meier survival estimates were used to compare unadjusted 5-year survival. RESULTS: Of the 15,022 patients (R = 10.4%, L = 44.3%, O = 45.3%), 63.2% were stage I and 70.6% underwent partial gastrectomy. MIS approach was associated with shorter hospital LOS (β: - 2.58; 95% CI: - 2.82 to - 2.33) and lower odds of 30-day (OR 0.45; 95% CI: 0.30-0.68) and 90-day mortality (OR 0.54; 95% CI: 0.39-0.74) compared to O. Likelihood of R0 resection similar between groups (OR 1.00; 95% CI: 0.88-1.14). Hospital LOS (β: + 0.25; 95% CI: - 0.14-0.64), odds of 30-day (OR 0.99; 95% CI: 0.40-2.46) and 90-day mortality (OR 0.89; 95% CI: 0.47-1.70), and rate of R0 resection (OR 1.02; 95% CI: 0.82-1.27) were comparable between R and L cohorts. Compared to O, MIS approach was associated with improved 5-year OS (log rank p < 0.001). Overall survival was not significantly different between R and L (log rank p = 0.44). CONCLUSION: These findings suggest that MIS approach may be considered for resection of gastric GIST in select patients. Among patients receiving an MIS approach, the robotic technique can be considered an oncologically safe alternative to laparoscopic surgery.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Freeman HD, Mudgway R, Tran Z, et al. Oncologic outcomes and survival of modern surgical approaches for gastric gastrointestinal stromal tumor (GIST). Surg Endosc. 2024. PMID: 39179690. doi:10.1007/s00464-024-11152-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。